US 2006/0135574 A1 · Novel uses for estrogen beta agonists

Abstract

This invention provides methods for treating cognitive diseases or disorders and symptoms thereof with estrogen beta selective agonists.

Dependent claims

A method for treating Parkinson's disease comprising the steps of:

a) identifying a patient having said disease;
and
b) administering to said patient a therapeutically effective amount of an ERβ selective ligand, wherein said ERβ selective ligand is substantially free of ERβ antagonist activity.

A method for ameliorating a symptom of Parkinson's disease comprising the steps of:

a) identifying a patient having said disease and having said symptom thereof;
and
b) administering to said patient a therapeutically effective amount of an ERβ selective ligand, wherein said ERβ selective ligand is substantially free of ERβ antagonist activity.

A method for ameliorating a symptom of a cognitive disease or disorder comprising the steps of:

a) identifying a patient having said cognitive disease or disorder and having said symptom thereof;
and
b) administering to said patient a therapeutically effective amount of an ERβ selective ligand, wherein said ERβ selective ligand is substantially free of ERβ antagonist activity;
and
wherein said disease or disorder is selected from multiple sclerosis, depression, schizophrenia, stroke, Alzheimer's disease or anxiety.

2 more elements

Dependencies are inferred from the claim text.